QDEL (QuidelOrtho) Research & Development: $178 Mil (TTM As of Mar. 2026)


QDEL QuidelOrtho Corp QDEL
47 GF Score
Price $13.52
GF Value $37.28
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is QuidelOrtho Research & Development?

QuidelOrtho QDEL +10.73% 47 Research & Development is $178 Mil as of Mar. 2026. GuruFocus rates QDEL with a GF Score™ of 47/100 and a GF Value™ of $37.28 (Possible Value Trap). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. QuidelOrtho's Research & Development for the three months ended in Mar. 2026 was $45 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $178 Mil.

QuidelOrtho  (NAS:QDEL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

QuidelOrtho Research & Development Related Terms

QuidelOrtho Research & Development Historical Data

* Premium members only.

The historical data trend for QuidelOrtho's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuidelOrtho Research & Development Chart

QuidelOrtho Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 95.70 187.90 245.00 218.70 186.20

QuidelOrtho Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.20 45.70 41.50 45.80 44.90
QDEL
47GF Score
QuidelOrtho Corp QDEL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QuidelOrtho Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $178 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $178 Mil mean?
QuidelOrtho (QDEL) has a Research & Development of $178 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on QuidelOrtho and its competitors.
Is QuidelOrtho's Research & Development too high?
QuidelOrtho's current Research & Development is $178 Mil. Overall, QuidelOrtho has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does QuidelOrtho's Research & Development compare to INMD and AVR?
QuidelOrtho's Research & Development of $178 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on QuidelOrtho and its competitors. QuidelOrtho's current Research & Development is $178 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QuidelOrtho stock overvalued right now?
Based on GuruFocus' analysis, QuidelOrtho (QDEL) is currently considered Possible Value Trap. The stock's GF Value™ is $37.28, compared to a current price of $13.52 — trading 63.7% below its estimated fair value. The current Research & Development is $178 Mil. QuidelOrtho's overall GF Score™ is 47/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For QuidelOrtho (QDEL), the current Research & Development is $178 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is QuidelOrtho (QDEL) Overvalued in 2026?

Based on GuruFocus' analysis, QuidelOrtho stock appears to be undervalued. The current stock price of $13.52 is trading 63.7% below its estimated GF Value™ of $37.28. GuruFocus considers QuidelOrtho to be Possible Value Trap.

Key valuation signals for QDEL:

  • Research & Development: $178 Mil
  • GF Value™: $37.28 vs. price of $13.52 (63.7% below fair value)
  • GF Score™: 47/100 with 8 warning signs

No single metric tells the full story. See the QDEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

QuidelOrtho Business Description

Other Exchanges 0A55:UKQL1A:Germany
Address 9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
47GF Score

Get the complete analysis for QDEL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.52
Price
$37.28
GF Value